What is the target of Marksan Pharma?
What is the target of Marksan Pharma?
View 1 reports from 1 analysts offering long term price targets for Marksans Pharma Ltd.. Marksans Pharma Ltd. has an average target of 87.00. The consensus estimate represents an upside of 41.58% from the last price of 61.45.
Who invested in Marksans Pharma?
HISTORICAL FII HOLDING
| Name | Holding Sep 2021 | |
|---|---|---|
| % | shares | |
| Mukul mahavir prasad agrawal | 1.47 | 6,000,000 |
| Individual share capital upto Rs. 2 Lacs | 35.26 | 144,341,389 |
| Any Other | 6.17 | 25,257,657 |
Who is the owner of Marksans Pharma?
Mark Saldanha
Mark Saldanha is the Chairman and Managing Director of Marksans. He set out with a vision to create a global pharmaceutical company.
What does marksans Pharma produce?
Formulation– This division is engaged in manufacturing of tablets, non–sterile liquids, ointments and powder products. The company owns one of the biggest manufacturing facility for soft gelatin in Asia . The company’s manufacturing plants are located at Goa and UK .
Is Hfcl a good stock to buy?
As on 29th Dec 2021 HFCL Share Price closed @ 80.35 and we RECOMMEND N/A for LONG-TERM with Stoploss of 0.00 & N/A for SHORT-TERM with Stoploss of 0.00 we also expect STOCK to react on Following IMPORTANT LEVELS.
Is Glenmark Pharmaceuticals Indian company?
Glenmark Pharmaceuticals Limited is an Indian pharmaceutical company headquartered in Mumbai, India that was founded in 1977 by Gracias Saldanha as a generic drug and active pharmaceutical ingredient manufacturer; he named the company after his two sons.
Is marksans Pharma A MNC?
Marksans Goes Global Tie-ups with leading global MNC’s for offering CRAMS. Setting up of specialized and state-of-the-art soft gel manufacturing facilities.
Will Pharma Mumbai address?
Address: Will Pharma Gulab Estate, T2 Terminal International Airport, MTNL Road, Sakinaka, Andheri, Mumbai, Maharashtra 400072.
Is HFCL owned by Reliance?
Reliance Industries (RIL) has increased its stake in HFCL, the country’s largest integrated telecom network provider, to 5% by investing ₹138 crore in the latter’s qualified institutional placement (QIP) that concluded on Thursday, people aware of the development told ET.
What is the rank of Glenmark company in India?
13th
As per IQVIA MAT March 2018, Glenmark’s India business is ranked 13th with a market share of 2.29%. Glenmark is the 2nd fastest growing company as per MAT March 2018 (among the Top 20 companies).
Who is the founder of Glenmark?
Gracias Saldanha
Glenmark Pharmaceuticals/Founders
What is the history of Marksans Pharma Ltd?
Marksans Pharma Ltd., incorporated in the year 1992, is a Small Cap company (having a market cap of Rs 1223.85 Crore) operating in Pharmaceuticals and health care sector.
Is Marksans Pharma’s metformin FDA approved?
The company has been granted the US Food and Drug Administration (USFDA) approval for Metformin Hydrochloride extended release tablets in the strengths of 500 mg and 750 mg, Marksans Pharma said in a BSE filing today.
When is the meeting of the Board of directors of Marksans?
MARKSANS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2021 ,inter alia, to consider and approve the Unaudited Financial Results of the Company (both Standalone and Consolidated) for the Quarter ended 30th June, 2021.
Did Marksans Pharma buy time-cap laboratories?
Drug maker Marksans Pharma today acquired US-based Time-Cap Laboratories for an undisclosed amount. The acquisition was done through its wholly-owned subsidiary, Marksans Pharma. Sorry, there are no blogs for your search.
